ES2531367T3 - Composición antivírica sinérgica y uso de la misma - Google Patents

Composición antivírica sinérgica y uso de la misma Download PDF

Info

Publication number
ES2531367T3
ES2531367T3 ES10810910T ES10810910T ES2531367T3 ES 2531367 T3 ES2531367 T3 ES 2531367T3 ES 10810910 T ES10810910 T ES 10810910T ES 10810910 T ES10810910 T ES 10810910T ES 2531367 T3 ES2531367 T3 ES 2531367T3
Authority
ES
Spain
Prior art keywords
antiviral composition
synergistic antiviral
infection
influenza virus
caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10810910T
Other languages
English (en)
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Christiane Meier
Marielle König-Schuster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marinomed Biotech AG
Original Assignee
Marinomed Biotechnologie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44063696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2531367(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Marinomed Biotechnologie GmbH filed Critical Marinomed Biotechnologie GmbH
Application granted granted Critical
Publication of ES2531367T3 publication Critical patent/ES2531367T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Carragenina iota y/o kappa junto con un inhibidor de la neuraminidasa para su uso como un medicamento en un tratamiento profiláctico o terapéutico combinado de un síntoma, afección o enfermedad causados por, o asociados a, una infección por un virus de influenza o causados por, o asociados a, una infección concomitante por un virus de influenza y al menos un virus respiratorio diferente.
ES10810910T 2009-12-22 2010-12-17 Composición antivírica sinérgica y uso de la misma Active ES2531367T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28214809P 2009-12-22 2009-12-22
PCT/EP2010/007726 WO2011076367A2 (en) 2009-12-22 2010-12-17 Synergistic antiviral composition and use thereof

Publications (1)

Publication Number Publication Date
ES2531367T3 true ES2531367T3 (es) 2015-03-13

Family

ID=44063696

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10810910T Active ES2531367T3 (es) 2009-12-22 2010-12-17 Composición antivírica sinérgica y uso de la misma

Country Status (21)

Country Link
US (1) US10022449B2 (es)
EP (1) EP2515889B1 (es)
JP (1) JP5902628B2 (es)
KR (1) KR101862415B1 (es)
CN (1) CN102652017A (es)
AU (1) AU2010335594B2 (es)
BR (1) BR112012015202B1 (es)
CA (1) CA2779532C (es)
CL (1) CL2012001695A1 (es)
DK (1) DK2515889T3 (es)
EA (1) EA022840B1 (es)
ES (1) ES2531367T3 (es)
IL (1) IL219552A (es)
MX (1) MX2012007166A (es)
NZ (1) NZ599839A (es)
PL (1) PL2515889T3 (es)
PT (1) PT2515889E (es)
SG (1) SG181421A1 (es)
SI (1) SI2515889T1 (es)
WO (1) WO2011076367A2 (es)
ZA (1) ZA201202482B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126777A1 (en) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition of neuraminidase activity
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
ES2734269T3 (es) * 2014-01-22 2019-12-05 Visufarma B V Composición que comprende carragenina tipo iota contra conjuntivitis viral
CN109069520A (zh) * 2016-02-25 2018-12-21 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
US11304989B2 (en) * 2017-10-06 2022-04-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Peptides for use in the treatment of viral infections
WO2019160261A1 (ko) * 2018-02-14 2019-08-22 (주)나노메디카 항바이러스 처리 방법, 항바이러스 필터, 및 이를 구비한 마스크
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
WO2021002355A1 (ja) * 2019-07-03 2021-01-07 アイリス株式会社 インフルエンザウイルス感染症を治療するための医薬組成物
CN116209435A (zh) * 2020-03-18 2023-06-02 因斯特科技公司 用于治疗冠状病毒感染和呼吸功能损伤的组合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593314B1 (en) * 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤
BRPI0720054A2 (pt) 2006-12-05 2013-12-17 Marinomed Biotechnologie Gmbh Uso de iota-carragenano, item de higiene ou sanitário sólido, e, iota-carragenano
EP1930015A1 (en) * 2006-12-05 2008-06-11 Marinomed Biotechnologie GmbH Use of carrageenan for treating rhinovirus infections
WO2008147468A2 (en) * 2006-12-18 2008-12-04 Amcol International Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use
EP2178533B1 (en) * 2007-08-24 2013-03-27 Marinomed Biotechnologie GmbH Antiviral composition comprising a sulfated polysaccharide: iota-carrageenan

Also Published As

Publication number Publication date
KR101862415B1 (ko) 2018-05-29
JP2013515022A (ja) 2013-05-02
SG181421A1 (en) 2012-07-30
CA2779532C (en) 2018-05-22
CA2779532A1 (en) 2011-06-30
CL2012001695A1 (es) 2013-03-08
EA022840B1 (ru) 2016-03-31
PL2515889T3 (pl) 2015-05-29
PT2515889E (pt) 2015-03-20
JP5902628B2 (ja) 2016-04-13
AU2010335594A1 (en) 2012-05-24
MX2012007166A (es) 2012-07-23
ZA201202482B (en) 2012-12-27
KR20120107970A (ko) 2012-10-04
IL219552A0 (en) 2012-06-28
US20120302522A1 (en) 2012-11-29
NZ599839A (en) 2014-02-28
AU2010335594B2 (en) 2015-05-21
WO2011076367A3 (en) 2011-09-01
BR112012015202A2 (pt) 2016-04-05
US10022449B2 (en) 2018-07-17
DK2515889T3 (en) 2015-03-02
IL219552A (en) 2016-11-30
EP2515889A2 (en) 2012-10-31
BR112012015202B1 (pt) 2020-12-08
EA201290373A1 (ru) 2012-11-30
SI2515889T1 (sl) 2015-04-30
EP2515889B1 (en) 2014-12-10
CN102652017A (zh) 2012-08-29
WO2011076367A2 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
ES2531367T3 (es) Composición antivírica sinérgica y uso de la misma
CY1122291T1 (el) Αναστολeις ιικου αναδιπλασιασμου
PH12014501984A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
CY1119216T1 (el) Φαρμακευτικη συνθεση για εισπνοη
CL2012001959A1 (es) Compuestos derivados del acido tiofeno-2-carboxilico, inhibidores de virus flaviviridae; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral por flaviviridae.
IN2012DN02805A (es)
BR112013022789A2 (pt) composições farmacêuticas que compreendem metformina e um inibidor dpp-4 ou um inibidor sglt-2
NZ601018A (en) Ev576 for use in the treatment of viral infections of the respiratory tract
NO20100097L (no) Antiviral sammensetning omfattende sulfatert polysakkarid
CO6460772A2 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
UY33370A (es) Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización
UA108072C2 (uk) Засіб для профілактики і лікування високопатогенних інфекційних захворювань
ECSP099685A (es) Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c
PH12015502230B1 (en) Novel viral replication inhibitors
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
MX350282B (es) Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas.
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
FR2969926B1 (fr) Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
MX347911B (es) Vacuna contra virus de diarrea viral de bovinos.
MX2010000120A (es) Estereoisomeros de triciclodecan-9-il-xantogenato.
CL2014003116A1 (es) Compuestos derivados de metanotiona,con actividad antiviral; metodo de preparacion; composicion farmaceutica; y un metodo de tratamiento de una infeccion viral, tal que la infeccion viral es influenza
WO2012138911A3 (en) Conjugates of anti-hiv drugs and somatostatin analogs
EA201370058A1 (ru) Средство против вируса гриппа b
ATE499108T1 (de) Verwendung von extrakten von cistus incanus zur herstellung eines medikaments zur prävention und/oder behandlung von grippe
PH12019501907A1 (en) Novel viral replication inhibitors